A cross-disease, pleiotropy-driven approach for therapeutic target prioritization and evaluation.
Journal article
Bao C. et al, (2024), Cell Rep Methods
Priority index for critical Covid-19 identifies clinically actionable targets and drugs.
Journal article
Zhang Z. et al, (2024), Commun Biol, 7